PDEX (Pro-Dex Inc New) Stock Analysis - Analyst Ratings

Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of May 21, 2026, PDEX trades at $63.59 with a market cap of $188.88M and a P/E ratio of 18.23. PDEX moved +2.55% today. Year to date, PDEX is +63.92%; over the trailing twelve months it is +42.41%. Its 52-week range spans $23.47 to $70.26. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate PDEX?

The average price target is $0.00.

PDEX Key Metrics

Key financial metrics for PDEX
MetricValue
Price$63.59
Market Cap$188.88M
P/E Ratio18.23
EPS$3.48
Dividend Yield0.00%
52-Week High$70.26
52-Week Low$23.47
Volume2
Avg Volume0
Revenue (TTM)$72.10M
Net Income$2.52M
Gross Margin28.29%

PDEX Analyst Consensus

PDEX analyst coverage data. Average price target: $0.00.

Latest PDEX News

Recent PDEX Insider Trades

  • CABILLOT RAYMOND E sold 7.26K (~$363.22K) on Apr 1, 2025.
  • CABILLOT RAYMOND E sold 836 (~$41.80K) on Mar 31, 2025.
  • CABILLOT RAYMOND E sold 842 (~$42.10K) on Mar 28, 2025.

Common questions about PDEX

What do analysts rate PDEX?
The average price target is $0.00.
Does Rallies show PDEX price targets?
Yes. Rallies tracks PDEX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is PDEX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PDEX. It does not provide personalized investment advice.
PDEX

PDEX